{
    "eid": "2-s2.0-85089418520",
    "title": "Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool",
    "cover-date": "2020-08-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Geriatrics and Gerontology",
            "@code": "2717",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Abnormal involuntary rating scale",
        "Antipsychotics",
        "Assessment tools",
        "Rating scales",
        "Tardive dyskinesia"
    ],
    "authors": [
        "Roongroj Bhidayasiri",
        "John M. Kane",
        "Karen P. Frei",
        "Stanley N. Caroff",
        "Christoph U. Correll",
        "Stanley Fahn",
        "Joseph Jankovic",
        "Robert A. Hauser",
        "Daniel D. Truong"
    ],
    "citedby-count": 3,
    "ref-count": 61,
    "ref-list": [
        "The nosology of tardive syndromes",
        "Tardive syndromes",
        "Effect of tardive dyskinesia on quality of life in patients with bipolar disorder, major depressive disorder, and schizophrenia",
        "Neurological symptoms in pharmacotherapy of psychoses",
        "Heterogeneity of tardive dyskinesia. A multivariate analysis",
        "Tardive dyskinesia: out of the shadows",
        "Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs",
        "Tardive akathisia: an analysis of clinical features and response to open therapeutic trials",
        "Setting the record straight: the nosology of tardive syndromes",
        "Reversible drug-induced parkinsonism. Clinicopathologic study of two cases",
        "Clinical correlates of the pathology underlying parkinsonism: a population perspective",
        "Neuroleptic-induced parkinsonism: clinicopathological study",
        "New nomenclature for drug-induced movement disorders including tardive dyskinesia",
        "Neuroleptic-induced tardive dyskinesia variants",
        "Evidence-based guideline: treatment of tardive syndromes: report of the guideline development subcommittee of the American Academy of Neurology",
        "Tardive dystonia in a psychiatric hospital",
        "The natural history of tardive dystonia. A long-term follow-up study of 107 cases",
        "Tardive dyskinesia: epidemiology",
        "Chronic involuntary movements induced by phenothiazines",
        "Persistent muscular restlessness after phenothiazine treatment: report of 3 cases",
        "Akathisia: an updated review focusing on second-generation antipsychotics",
        "Akathisia variants and tardive dyskinesia",
        "Revisiting the abnormal involuntary movement scale: proceedings from the tardive dyskinesia assessment workshop",
        "Manual for the extrapyramidal symptom rating scale (ESRS)",
        "The schedule for the assessment of drug-induced movement disorders (SADIMoD): test-retest reliability and concurrent validity",
        "Metric characteristics of the drug-induced extrapyramidal symptoms scale (DIEPSS): a practical combined rating scale for drug-induced movement disorders",
        "A critical review of rating scales in the assessment of movement disorders in schizophrenia",
        "Which dyskinesia scale best detects treatment response?",
        "Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations",
        "Clinical research techniques in tardive dyskinesia",
        "Development of a screening program for tardive dyskinesia: feasibility issues",
        "How to examine patients using the abnormal involuntary movement scale",
        "Assessment of tardive dyskinesia using the abnormal involuntary movement scale",
        "Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study",
        "Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial",
        "Kinect 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia",
        "A rating scale for tardive dyskinesia",
        "The Maryland Psychiatric Research Center scale and the characterization of involuntary movements",
        "Psychometric properties of the dyskinesia identification system: condensed user scale (DISCUS)",
        "The St. Hans Rating Scale for extrapyramidal syndromes: reliability and validity",
        "Reliability, validity, and a total score cutoff for the dyskinesia identification system: condensed user scale (DISCUS) with mentally ill and mentally retarded populations",
        "Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials",
        "I. Clinical antipsychotic trials of intervention effectiveness, extrapyramidal side-effects of antipsychotics in a randomised trial",
        "Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis",
        "Tardive dyskinesia: age and sex differences in hospitalized schizophrenics",
        "Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables",
        "The course of tardive dyskinesia in patients on long-term neuroleptics",
        "Prevalence of tardive dyskinesia in affective disorder patients",
        "Effects of intravenous metoclopramide in 81 patients with tardive dyskinesia",
        "Effect of antipsychotic type and dose changes on tardive dyskinesia and parkinsonism severity in patients with a serious mental illness: the curacao extrapyramidal syndromes study XII",
        "Abnormal involuntary movement scale in tardive dyskinesia: minimal clinically important difference",
        "Fluctuation of tardive dyskinesia",
        "Diurnal variability of orofacial dyskinetic movements",
        "Neurostimulation in tardive dystonia/dyskinesia: a delayed start, sham stimulation-controlled randomized trial",
        "Sensory aspects of movement disorders",
        "Movement disorder society-sponsored revision of the unified Parkinson's disease rating scale (MDS-UPDRS): process, format, and clinimetric testing plan",
        "The end of a cycle: a unique perspective in the evolution of movement disorders",
        "A rating scale for tardive dyskinesia and Parkinsonian symptoms",
        "Effects of drug withdrawal on tardive dyskinesia",
        "Effects of dopamine agonists in tardive dyskinesia",
        "Reliability and validity of a tardive dyskinesia videotape rating technique"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hempstead",
            "@id": "60107658",
            "affilname": "Donald and Barbara Zucker School of Medicine at Hofstra/Northwell",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60107658",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Fountain Valley",
            "@id": "60087785",
            "affilname": "Parkinson's and Movement Disorder Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60087785",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Loma Linda",
            "@id": "60030806",
            "affilname": "Loma Linda University Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030806",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Riverside",
            "@id": "60029526",
            "affilname": "University of California, Riverside",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029526",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "New York",
            "@id": "60027565",
            "affilname": "Columbia University Irving Medical Center",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027565",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Berlin",
            "@id": "60026245",
            "affilname": "Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026245",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "New York",
            "@id": "60020942",
            "affilname": "Zucker Hillside Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020942",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Manhasset",
            "@id": "60020804",
            "affilname": "Feinstein Institute for Medical Research",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60020804",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tampa",
            "@id": "60007740",
            "affilname": "University of South Florida, Tampa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60007740",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Philadelphia",
            "@id": "60003711",
            "affilname": "University of Pennsylvania Perelman School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60003711",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Houston",
            "@id": "60002441",
            "affilname": "Baylor College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002441",
            "affiliation-country": "United States"
        }
    ],
    "funding": [
        "Daiichi Sankyo Pharma",
        "Emalex Biosciences, Inc",
        "Intec Pharma Ltd",
        "Ipsen, Merz, Auspex",
        "Janssen and Takeda",
        "Osmotica Pharmceuticals and Dispersol Technologies",
        "National Institutes of Health",
        "National Institute of Neurological Disorders and Stroke",
        "Michael J Fox Foundation for Parkinson Research",
        "CHDI Foundation",
        "Teva Pharmaceutical Industries",
        "AbbVie",
        "F. Hoffman-La Roche",
        "Sunovion Pharmaceuticals",
        "Newton Fund",
        "Parkinson Foundation",
        "Acadia Pharmaceuticals",
        "Dystonia Coalition",
        "Neurocrine Biosciences",
        "Revance Therapeutics Inc",
        "Chulalongkorn university",
        "Thailand Research Fund",
        "Merz Pharmaceuticals"
    ]
}